Cosmetic Talc Can Cause Mesothelioma, Study Finds
A new study in the American Journal of Industrial Medicine appears to offer definitive evidence that repeated exposure to cosmetic talc can cause mesothelioma. It is an issue that has come up repeatedly in courtrooms in recent years. Lawyers for mesothelioma patients who have used cosmetic talc say the products are unsafe. Manufacturers like Johnson & Johnson insist they are pure. But the new study shows that may not be the case. If the product is contaminated with asbestos, as many appear to be, the study shows cosmetic talc can cause mesothelioma. How Can Cosmetic Talc Cause Mesothelioma? Talcum powder is made from talc, which contains magnesium and silicon. Because it absorbs moisture, people use it to keep skin dry … Continue reading Cosmetic Talc Can Cause Mesothelioma, Study Finds
Possible New Drug for Mesothelioma Gets First FDA Approval
A possible new drug for mesothelioma has received FDA approval for the treatment of advanced epithelioid sarcoma. Tazemetostat (Tazverik) is an oral medication made by a company called Epizyme. It is a brand new kind of drug that blocks a protein called EZH2. Tazemetostat is in testing for several different types of cancer, including malignant mesothelioma. The recent FDA approval is an encouraging sign that it could one day be a new drug for mesothelioma. In Search of a New Drug for Mesothelioma Malignant mesothelioma is one of the most serious consequences of exposure to asbestos. Once asbestos fibers get into the lungs and other tissues, they never leave. Their presence sets up a cascade of cellular reactions that can … Continue reading Possible New Drug for Mesothelioma Gets First FDA Approval
Surgery Extends Survival for Patients with Pleural Mesothelioma
Patients with pleural mesothelioma who choose to have surgery live longer than those who do not. This applies no matter which kind of surgery they have. That is the conclusion of a Mexican study published in the Annals of Oncology. Doctors with the country’s National Institute for Respiratory Diseases conducted the study. It included 122 pleural mesothelioma patients. The researchers analyzed a wide range of variables like age, sex, asbestos exposure, and overall health. They discovered that the decision to have surgery was one of the most important survival factors in patients with pleural mesothelioma. Treatment Options for Patients with Pleural Mesothelioma Pleural mesothelioma is an aggressive cancer with no known cure. It usually occurs in people who have been … Continue reading Surgery Extends Survival for Patients with Pleural Mesothelioma
Targeted Radiotherapy for Mesothelioma May Extend Survival in the Right Patients
A meta-analysis conducted by some of the country’s top cancer researchers says targeted radiotherapy for mesothelioma can help some people live longer. It is the first such analysis of targeted radiation after lung-sparing mesothelioma surgery. The team focused on intensity modulated radiation therapy (IMRT). IMRT is more precise than earlier forms of radiation treatment. The new article appears in Practical Radiation Oncology. It is a meta-analysis of ten smaller studies. The researchers conclude that healthier surgery patients could safely consider targeted radiotherapy for mesothelioma. Making Radiotherapy Less Toxic In the past, radiation for mesothelioma has sometimes done more harm than good. Earlier types of radiation treatment were not as precise as IMRT. When radiation spills over into healthy tissue, it … Continue reading Targeted Radiotherapy for Mesothelioma May Extend Survival in the Right Patients
Can These Compounds Protect Against the Toxic Effects of Asbestos?
A recent study out of Australia suggests that compounds called zeolites might offer protection against the toxic effects of asbestos. Asbestos is the primary cause of malignant mesothelioma. Mesothelioma is a rare and aggressive cancer for which there is no cure. There is no way to remove asbestos from the body after a person has been exposed. But the new study suggests that zeolites might counteract some of the toxic effects of asbestos. If the impact can be validated in humans, it could one day change the outcomes for thousands of people at risk for mesothelioma. What Are the Toxic Effects of Asbestos? Asbestos is a naturally-occurring mineral made up of long microscopic fibers. The size and shape of these … Continue reading Can These Compounds Protect Against the Toxic Effects of Asbestos?
Deep Vein Thrombosis After Pleurectomy for Mesothelioma
The authors of a new study on deep vein thrombosis after pleurectomy say mesothelioma patients may be at special risk. They say routine screening after pleural mesothelioma surgery could save lives. The study comes from Brigham and Women’s Hospital, a leader in cancer research. The research team followed a series of mesothelioma patients who agreed to be part of a DVT surveillance program. Nearly 30 percent of the patients experienced deep vein thrombosis after pleurectomy. A third of those patients had no symptoms. Understanding DVT Deep vein thrombosis or DVT is when a blood clot forms in the deep veins of the arm, leg, or groin. If the clot goes unnoticed, it can travel through the circulation and lodge in … Continue reading Deep Vein Thrombosis After Pleurectomy for Mesothelioma
Mesothelioma in Women: Study Reveals Diagnostic Trends
A major study of mesothelioma in women finds that women tend to contract the disease earlier in life than men do. The analysis included 354 cases of malignant mesothelioma from a database of more than 2,800. While the average age for pleural mesothelioma diagnosis is 72, the average age for women to be diagnosed with any type of mesothelioma was just 60. It could mean that the latency period for mesothelioma is shorter for women than it is in men. It could also mean that women are more attuned to mesothelioma symptoms and recognize the disease sooner. Mesothelioma’s Long Latency The latency period is the time between exposure to a cancer-causing agent and the occurrence of cancer. Mesothelioma has one … Continue reading Mesothelioma in Women: Study Reveals Diagnostic Trends
Immunotherapy with ONCOS-102 Shows Promise for Mesothelioma
Early results are in on the latest trial of immunotherapy with ONCOS-102 and the news is good for pleural mesothelioma patients. Norweigian drug maker Targovax released the news about ONCOS-102 earlier this week. The new drug is based on an oncolytic virus that targets mesothelioma cells. When the virus gets inside the cells, it triggers an immune response. Early tests of immunotherapy with ONCOS-102 showed it helped mesothelioma chemotherapy work better. Now, a larger study appears to confirm the effect. The news could lead to new and better treatments for this intractable cancer. What is an Oncolytic Virus? An oncolytic virus is a virus that targets cancer cells. ONCOS-102 was designed to seek out mesothelioma cells. It is made out … Continue reading Immunotherapy with ONCOS-102 Shows Promise for Mesothelioma
Multidisciplinary Care for Mesothelioma
Italian doctors say patients are more likely to enter clinical trials when they have multidisciplinary care for mesothelioma. Inclusion in clinical trials is one of the best ways for mesothelioma patients to access cutting edge treatments. The study shows multidisciplinary care for mesothelioma helps funnel patients into trials. It also provides better monitoring of treatment response and better access to palliative care. What is the Multidisciplinary Approach? In most hospitals, mesothelioma patients receive diagnosis from a cancer doctor or oncologist. The oncologist orders the appropriate diagnostic tests and helps craft the treatment plan. Diagnostic imaging or radiotherapy for mesothelioma is usually overseen by radiology specialists. But multidisciplinary care for mesothelioma involves a bigger team of people. The team consists of … Continue reading Multidisciplinary Care for Mesothelioma
Sarcomatoid Mesothelioma Treatment Focuses on Two-Drug Combo
Researchers in Spain are developing what they hope will be a more effective sarcomatoid mesothelioma treatment. The new treatment focuses on a pair of drugs that are already being tested in humans. Mesothelioma impacts about 2,500 Americans each year. Sarcomatoid mesothelioma is a rare form of this rare cancer. About a quarter of the annual cases are sarcomatoid. This form of cancer is even more aggressive than epithelioid mesothelioma. But sarcomatoid mesothelioma treatment is not significantly different. Neither are the results. But the new study could change the prognosis for people with asbestos cancer. It appears in the journal Cancer Research. Chemotherapy is the Primary Sarcomatoid Mesothelioma Treatment Most people with malignant mesothelioma receive chemotherapy with cisplatin and Alimta. This … Continue reading Sarcomatoid Mesothelioma Treatment Focuses on Two-Drug Combo
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!